Retrieve available abstracts of 15 articles: HTML format
Single Articles
July 2025
SUZUKI K, Levert A, Yoo E, Cysique LA, et al Higher levels of cell-associated HIV-1 RNA transcripts predict risk of viral
blips: implications for clinical management and cure research.
AIDS. 2025;39:1300-1302. PubMedAbstract available
June 2025
BERNAL E, Martinez-Rodriguez R, Gomez JM, Tomas C, et al Low-level viremia linked to virological failure but not clinical events: a
competing risks study.
AIDS. 2025 Jun 3. doi: 10.1097/QAD.0000000000004248. PubMedAbstract available
August 2024
NEARY J, Chebet D, Benki-Nugent S, Moraa H, et al Association between HIV and cytomegalovirus and neurocognitive outcomes among
children with HIV.
AIDS. 2024 Aug 29. doi: 10.1097/QAD.0000000000004000. PubMedAbstract available
ALDREDGE A, Mehta CC, Lahiri CD, Schneider MF, et al Consequences of low-level viremia among women with HIV in the United States from
2003 - 2020.
AIDS. 2024 Aug 7. doi: 10.1097/QAD.0000000000003990. PubMedAbstract available
July 2024
MANN SC, Tong W, Abraham AG, Palella F, et al The impact of diabetes mellitus on HIV virologic control: results of the
MACS/WIHS combined cohort study.
AIDS. 2024 Jul 19. doi: 10.1097/QAD.0000000000003978. PubMedAbstract available
June 2024
SODEKE O, Milligan K, Ezeuko I, Oladipo A, et al Longitudinal viral load outcomes of adults with HIV after detectable viremia on
tenofovir, lamivudine, and dolutegravir.
AIDS. 2024 Jun 13. doi: 10.1097/QAD.0000000000003956. PubMedAbstract available
May 2024
WASILWA A, Amadi E, Ramadhani HO, Lascko T, et al Impact of enhanced adherence counselling on viral re-suppression among
adolescents and young persons with persistent viremia.
AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003945. PubMedAbstract available
January 2024
DUNCAN MC, Omondi FH, Kinloch NN, Lapointe HR, et al Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.
AIDS. 2024 Jan 15. doi: 10.1097/QAD.0000000000003841. PubMedAbstract available
December 2023
DORWARD J, Govender K, Moodley P, Lessells R, et al Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and
viraemia in people taking efavirenz and dolutegravir based antiretroviral
therapy.
AIDS. 2023 Dec 19. doi: 10.1097/QAD.0000000000003818. PubMedAbstract available
October 2023
LARTEY M, Ganu VJ, Tachi K, Yang H, et al Association of tenofovir diphosphate and lamivudine triphosphate concentrations
with HIV and HBV viral suppression.
AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003764. PubMedAbstract available
September 2023
RACCAGNI AR, Diotallevi S, Lolatto R, Lucente MF, et al Viral blips and virologic failures following mpox vaccination with MVA-BN among
people with HIV.
AIDS. 2023 Sep 29. doi: 10.1097/QAD.0000000000003733. PubMedAbstract available
July 2023
CHUN HM, Milligan K, Boyd MA, Abutu A, et al Reaching HIV epidemic control in Nigeria using a lower HIV viral load suppression
cut-off.
AIDS. 2023 Jul 28. doi: 10.1097/QAD.0000000000003672. PubMedAbstract available
June 2023
LEES EA, Tickner N, Lyall H, Mcmaster P, et al Infant postnatal prophylaxis following maternal viraemia during breastfeeding.
AIDS. 2023;37:1185-1186. PubMed
February 2023
CHAISSON LH, Semitala FC, Nangobi F, Steinmetz S, et al Viral suppression among adults with HIV receiving routine dolutegravir-based
antiretroviral therapy and 3HP.
AIDS. 2023 Feb 8. doi: 10.1097/QAD.0000000000003508. PubMedAbstract available
January 2023
BOWMAN C, Ambrose A, Kanitkar T, Flores K, et al Real world use of dolutegravir two drug regimens.
AIDS. 2023 Jan 16. doi: 10.1097/QAD.0000000000003480. PubMedAbstract available